These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14585717)

  • 1. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering.
    Matzelle MM; Babensee JE
    Biomaterials; 2004 Jan; 25(2):295-304. PubMed ID: 14585717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen.
    Bennewitz NL; Babensee JE
    Biomaterials; 2005 Jun; 26(16):2991-9. PubMed ID: 15603794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection.
    Norton LW; Park J; Babensee JE
    J Control Release; 2010 Sep; 146(3):341-8. PubMed ID: 20595029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 9. Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid).
    Srinivasan S; Elizabeth Babensee J
    J Biomed Mater Res A; 2021 Nov; 109(11):2269-2279. PubMed ID: 33960123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
    Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.
    Bae HD; Lee J; Jin XH; Lee K
    Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models.
    Riehl M; Harms M; Lucas H; Ebensen T; Guzmán CA; Mäder K
    Eur J Pharm Sci; 2018 May; 117():88-97. PubMed ID: 29408551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement and regulation effect of myrcene on antibody response in immunization with ovalbumin and Ag85B in mice.
    Uyeda S; Sharmin T; Satho T; Irie K; Watanabe M; Hosokawa M; Hiramatsu Y; Koga T; Nakashima Y; Kashige N; Toda A; Mishima K; Miake F
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):314-323. PubMed ID: 27543726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo.
    Hamm S; Heit A; Koffler M; Huster KM; Akira S; Busch DH; Wagner H; Bauer S
    Int Immunol; 2007 Mar; 19(3):297-304. PubMed ID: 17289655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L; Benedetti R; Ferek GA; Massouh E; Fló J
    Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.
    Boscardin SB; Hafalla JC; Masilamani RF; Kamphorst AO; Zebroski HA; Rai U; Morrot A; Zavala F; Steinman RM; Nussenzweig RS; Nussenzweig MC
    J Exp Med; 2006 Mar; 203(3):599-606. PubMed ID: 16505139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.